BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 42 filers reported holding BIOTA PHARMACEUTIALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $337,000 | -20.3% | 224,977 | +3.1% | 0.04% | -16.0% |
| Q4 2015 | $423,000 | -27.1% | 218,177 | -25.5% | 0.05% | -39.0% |
| Q3 2015 | $580,000 | -4.3% | 292,807 | 0.0% | 0.08% | -5.7% |
| Q2 2015 | $606,000 | -10.0% | 292,807 | 0.0% | 0.09% | -23.0% |
| Q1 2015 | $673,000 | +2.6% | 292,807 | 0.0% | 0.11% | +20.2% |
| Q4 2014 | $656,000 | -29.8% | 292,807 | -22.6% | 0.09% | -36.9% |
| Q3 2014 | $934,000 | -9.1% | 378,107 | +4.8% | 0.15% | -32.9% |
| Q2 2014 | $1,028,000 | -46.1% | 360,668 | +15.6% | 0.22% | -57.2% |
| Q1 2014 | $1,907,000 | +17.6% | 312,068 | -19.4% | 0.52% | -11.4% |
| Q4 2013 | $1,622,000 | -2.2% | 387,048 | -2.4% | 0.59% | +62.8% |
| Q3 2013 | $1,658,000 | +21.1% | 396,677 | 0.0% | 0.36% | 0.0% |
| Q2 2013 | $1,369,000 | – | 396,677 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 729,781 | $2,080,000 | 1.97% |
| Healthcare Value Capital, LLC | 145,507 | $415,000 | 0.35% |
| Broadfin Capital, LLC | 2,244,266 | $6,396,000 | 0.32% |
| TOWERVIEW LLC | 225,000 | $641,000,000 | 0.31% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 360,668 | $1,028,000 | 0.22% |
| Dominick & Dominick LLC | 146,016 | $416,000 | 0.20% |
| BVF INC/IL | 435,900 | $1,242,000 | 0.20% |
| Perceptive Advisors | 253,400 | $722,000 | 0.07% |
| BAILARD, INC. | 115,000 | $328,000 | 0.05% |
| KNOTT DAVID M | 88,100 | $251,085,000 | 0.04% |